Yükleniyor...
Radar Rating
Good
5-dimension analyst performance assessment
Total Analyses
431
Buy
205
Sell
62
Hold
164
Unique Assets
10
Active Days
133+
Kanal Finans evaluates general strategies and market dynamics for investors while high inflation persists and pressure on the dollar exchange rate continues.
* Does not constitute investment advice
It is stated that it ranks high in the list of cheapest companies in the stock market according to the EV/EBITDA ratio.
* Does not constitute investment advice
It is emphasized that it is among the stocks defined as "very cheap" according to their multiples and liked by analysts.
* Does not constitute investment advice
It is examined in the group of companies described as "truly very cheap" in fundamental analysis filterings.
* Does not constitute investment advice
It is evaluated that although it is on the list and has some "Hold" recommendations, its general valuation is attractive.
* Does not constitute investment advice
It is analyzed that it is trading at a deep discount according to forward EV/EBITDA and P/BV (0.63) multiples and is on the analysts' favorite list.
* Does not constitute investment advice
It is evaluated that it has a 100% analyst approval rate and is among the most attractive stocks in the market based on fundamental multiples.
* Does not constitute investment advice
It is stated that it is included in the list of companies recommended by analysts and offering opportunities in terms of valuation.
* Does not constitute investment advice
It is examined as a healthcare sector stock located further down the list that meets the cheapness criteria.
* Does not constitute investment advice
It is interpreted as a discounted asset standing out with its low P/BV ratio and 67% analyst appreciation level.
* Does not constitute investment advice
